Adherence to the glibenclamide intervention was achieved in 9/13 (69.2%, 95%CI 38.6–90.9%) women, with 4 women switched to insulin therapy due to hyperglycaemia (n = 2) or hypoglycaemia (n = 2). Here, INS is linked to Hypoglycemia.